{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T17:56:18Z","timestamp":1773338178130,"version":"3.50.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,4]]},"DOI":"10.7759\/cureus.31092","type":"journal-article","created":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T16:32:21Z","timestamp":1667579541000},"source":"Crossref","is-referenced-by-count":3,"title":["COVID-19 Exposure Unmasking Systemic Amyloidosis With Hepatic Predominance"],"prefix":"10.7759","author":[{"given":"Jose R","family":"Russe-Russe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiya","family":"Abramowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James R","family":"Pellegrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Alvarez Betancourt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricky","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Baldino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Crandall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepthi","family":"Kagolanu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Mejia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaleem","family":"Rizvon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/01.md.0000091183.93122.c7","article-title":"Primary (AL) hepatic amyloidosis: clinical features and natural history in 98 patients","volume":"82","author":"Park MA","year":"2003","unstructured":"Park MA, Mueller PS, Kyle RA, Larson DR, Plevak MF, Gertz MA. Primary (AL) hepatic amyloidosis: clinical features and natural history in 98 patients. Medicine (Baltimore). 2003, 82:291-8. 10.1097\/01.md.0000091183.93122.c7","journal-title":"Medicine (Baltimore)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(88)90505-0","article-title":"Hepatic amyloidosis (primary [AL], immunoglobulin light chain): the Natural History in 80 patients","volume":"85","author":"Gertz","year":"1988","unstructured":"Gertz, MA, Kyle RA. Hepatic amyloidosis (primary [AL], immunoglobulin light chain): the Natural History in 80 patients. Am J Med. 1988, 85:73-80. 10.1016\/0002-9343(88)90505-0","journal-title":"Am J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01669.x","article-title":"Gastrointestinal manifestations of amyloidosis","volume":"103","author":"Ebert EC","year":"2008","unstructured":"Ebert EC, Nagar M. Gastrointestinal manifestations of amyloidosis. Am J Gastroenterol. 2008, 103:776-87. 10.1111\/j.1572-0241.2007.01669.x","journal-title":"Am J Gastroenterol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25149","article-title":"Immunoglobulin light chain amyloidosis: 2018 Update on diagnosis, prognosis, and treatment","volume":"93","author":"Gertz MA","year":"2018","unstructured":"Gertz MA. Immunoglobulin light chain amyloidosis: 2018 Update on diagnosis, prognosis, and treatment. Am J Hematol. 2018, 93:1169-80. 10.1002\/ajh.25149","journal-title":"Am J Hematol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2008.03682.x","article-title":"Review article: gastrointestinal amyloidosis - clinical features, diagnosis and therapy","volume":"27","author":"Petre S","year":"2008","unstructured":"Petre S, Shah IA, Gilani N. Review article: gastrointestinal amyloidosis - clinical features, diagnosis and therapy. Aliment Pharmacol Ther. 2008, 27:1006-16. 10.1111\/j.1365-2036.2008.03682.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-19724\/v1","article-title":"Serum amyloid A protein as a potential biomarker useful in monitoring the course of COVID-19: a retrospectively studied","volume":"19","author":"Zhang Y","year":"2020","unstructured":"Zhang Y, Wang D, Lin M, et al.. Serum amyloid A protein as a potential biomarker useful in monitoring the course of COVID-19: a retrospectively studied. Research Square. 2020, 19:10.21203\/rs.3.rs-19724\/v1","journal-title":"Research Square"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2021.03.025","article-title":"Serum amyloid A concentrations, COVID-19 severity and mortality: an updated systematic review and meta-analysis","volume":"105","author":"Zinellu A","year":"2021","unstructured":"Zinellu A, Paliogiannis P, Carru C, Mangoni AA. Serum amyloid A concentrations, COVID-19 severity and mortality: an updated systematic review and meta-analysis. Int J Infect Dis. 2021, 105:668-74. 10.1016\/j.ijid.2021.03.025","journal-title":"Int J Infect Dis"},{"key":"ref8","unstructured":"Gastrointestinal amyloidosis. clinical manifestations, diagnosis, and management. (2020). Accessed: October 3, 2018: https:\/\/www.darmzentrum-bern.ch\/fileadmin\/darmzentrum\/Education\/Bible_Class\/2020\/Amyloidosis\/BC_2020-03-11_VO_Amyloid...."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000454","article-title":"Systemic AL Amyloidosis: Current Approaches to Diagnosis and Management","volume":"4","author":"Fotiou D","year":"2020","unstructured":"Fotiou D, Dimopoulos MA, Kastritis E. Systemic AL Amyloidosis: Current Approaches to Diagnosis and Management. Hemasphere. 2020, 4:e454. 10.1097\/HS9.0000000000000454","journal-title":"Hemasphere"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018021261","article-title":"Delay treatment of AL amyloidosis at relapse until symptomatic: devil is in the details","volume":"3","author":"Sanchorawala V","year":"2019","unstructured":"Sanchorawala V. Delay treatment of AL amyloidosis at relapse until symptomatic: devil is in the details. Blood Adv. 2019, 3:216-8. 10.1182\/bloodadvances.2018021261","journal-title":"Blood Adv"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/resp.13840","article-title":"Serum amyloid A is a predictor for prognosis of COVID\u201019","volume":"25","author":"Mo X","year":"2020","unstructured":"Mo X, Su Z, Lei C, et al.. Serum amyloid A is a predictor for prognosis of COVID\u201019. Respirology. 2020, 25:764-5. 10.1111\/resp.13840","journal-title":"Respirology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/103402-covid-19-exposure-unmasking-systemic-amyloidosis-with-hepatic-predominance","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:47:37Z","timestamp":1707508057000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/103402-covid-19-exposure-unmasking-systemic-amyloidosis-with-hepatic-predominance"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,4]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.31092","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11,4]]}}}